Nyxoah SA - stock earnings
NYXH Quarterly earnings
Date | Earnings | Revenue |
---|---|---|
2023Q4 | -12.0 million USD | 2.0 million USD |
2023Q3 | -8.1 million USD | 1.0 million USD |
2023Q2 | -13.9 million USD | 1.2 million USD |
2023Q1 | -13.0 million USD | 480693 USD |
2022Q4 | -14.3 million USD | 1.4 million USD |
2022Q3 | -6.1 million USD | 178509 USD |
2022Q2 | -5.2 million USD | 977803 USD |
2022Q1 | -7.5 million USD | 736542 USD |
2021Q4 | -7.1 million USD | 335499 USD |
2021Q3 | -10.1 million USD | 235105 USD |
2021Q2 | -8.2 million USD | 201582 USD |
2021Q1 | -6.6 million USD | 216929 USD |
2020Q4 | -4.1 million EUR | 34500 EUR |
2020Q3 | -4.1 million EUR | 34500 EUR |
2020Q2 | -1.8 million USD | ? USD |
2020Q1 | -2.6 million USD | ? USD |
NYXH Yearly earnings
Date | Earnings | Revenue |
---|---|---|
2023 | -47.8 million USD | 4.8 million USD |
2022 | -33.5 million USD | 3.3 million USD |
2021 | -31.4 million USD | 968968 USD |
2020 | -14.9 million USD | 84033 USD |
2019 | -8.1 million USD | ? USD |
2018 | -10.4 million USD | ? USD |
2017 | -12.4 million USD | ? USD |
NYXH
Price: $10.70
52 week price:
Earnings Per Share: -1.67 USD
P/E Ratio: -6.97
Exchange: NGM
Sector: Healthcare
Industry: Medical Instruments & Supplies
Volume: 11600
Market Capitalization: 367.2 million